POCP Blog

Biosimilar Recommendation Means Challenges and Opportunities Ahead for HealthIT

By Tony Schueth, CEO & Managing Partner Biosimilars now are set to hit the US market with the recent recommendation that the government approve Novartis’s Zarxio cancer drug as a …

ePrescribing Requires Continued Industry Focus; More AzHeC-Like Initiatives Needed

By Tony Schueth, CEO & Managing Partner ePrescribing has become an integral component of healthcare delivery and the preferred method of prescribing non-controlled medications.  Last year,  58% of eligible non-controlled prescription …

Does formulary decision support improve patient compliance?

By Michael Burger, Senior Consultant Policymakers, payers and providers view health information technology (health IT) as a tool to help improve patients’ medication compliance, among its many benefits. This is important …

Electronic Prior Authorization – Now is Finally the Time

By Tony Schueth, CEO & Managing Partner If you want to hit the healthcare jackpot in 2015, there’s one place you should place your chips:   electronic prior authorization (ePA) for …

Why Physicians Will Take the Meaningful Use Penalties Rather Than Participate

By Michael Burger, Senior Consultant Another Meaningful Use (MU) attestation deadline is here. If the past is prologue, physician attestation rates will continue to be much lower than expected. This …

Diagnosis in ePrescribing – Now is the time for the next generation of ePrescribing!

By Michael Burger, Senior Consultant ePrescribing has now surpassed the “tipping point” with greater than 60% of prescriptions issued electronically. That percentage is expected to increase as the late adopters overcome …

Are your IT strategies for engaging patients working?

By Michael Solomon, PhD, MBA, Practice Lead, eCare Management Everyone is talking about ways to engage patients in their healthcare. Payers, providers, pharmaceutical manufacturers, and HIT vendors are making major investments …

Reimbursing Pharmacists for Patient Care Service: An Idea Whose Time is Overdue

By Tony Schueth Pharmacists are increasingly called on to work with other healthcare professionals to increase their participation in care services. Studies and experience have shown that pharmacists add value …

MU3 and WIIFM – Have we missed the boat?

By Michael Burger, Senior Consultant On March 11, the Health IT Policy Committee endorsed the Meaningful Use Workgroup’s recommendations for Meaningful Use Stage 3.  The Workgroup’s initial proposal was scaled …

Stopping Physician Overprescribing

By Maria Friedman, Senior Consultant The war on drug abuse is taking a turn with the growing spotlight on physician overprescribing. More fuel has been thrown on the fire with new …